Alice Gottlieb


Presentations

Effect of Metabolic Syndrome on Efficacy and Safety in Patients With Psoriasis Treated With Etanercept or Tildrakizumab: Post Hoc Analysis of 2 Phase 3 Clinical Studies (reSURFACE 1 and reSURFACE 2) 09 October 2019 00:00 - 00:00

Abstracts

Effect of Metabolic Syndrome on Efficacy and Safety in Patients With Psoriasis Treated With Etanercept or Tildrakizumab: Post Hoc Analysis of 2 Phase 3 Clinical Studies (reSURFACE 1 and reSURFACE 2) Psoriasis More